Skip to main content
. 2019 Apr 24;12:100. doi: 10.3389/fnmol.2019.00100

Figure 8.

Figure 8

Working model. Treatment with K6PC-5 stimulates the activity of SPHK1 with a subsequent increase in the levels of S1P. S1P may act either intracellularly, by stimulating autophagy and reducing mHtt aggregation, or extracellularly by stabilizing S1PR expression and activating pro-survival pathways.